U308 Corp. Provides Provisional Timetable For Share Consolidation and Adjusts Terms of Certain Outstanding Warrants.
posted on
Aug 23, 2017 09:57AM
Edit this title from the Fast Facts Section
Wednesday, August 23, 2017
TORONTO, Aug. 23, 2017 /CNW/ - U3O8 Corp. (TSX: UWE), (OTCQB: UWEFF) ("U3O8 Corp." or the "Company") reports on provisional timing of the consolidation of the Company's common shares and on the decision to amend the terms of certain common share purchase warrants.
Provisional Timetable for the Consolidation of the Company's Common Shares
Based on the approval of the Company's shareholders at the June 22, 2017 Annual & Special Meeting ("ASM"), the Company has received approval from the Toronto Stock Exchange ("TSX") to undertake a consolidation of one new share for twenty old shares on an effective basis. Shareholders with less than 1,000 old shares will be paid out for the value of those shares and will cease to be shareholders of the Corporation.
The consolidation is anticipated to be effective on September 11, 2017. A letter of transmittal has been mailed to shareholders and is available on the Company's profile on SEDAR, www.sedar.com, which provides all related details and instructions to shareholders.
As noted above, the effect of the consolidation depends on the number of shares held, as follows:
Amendment to Terms of Certain Warrants
The Board of the Company has decided to amend the terms of common share purchase warrants (the "warrants") that are due to expire close to the date of the share consolidation so that the holders of the warrants have a fairer opportunity to assess whether they want to exercise their warrants. The warrants affected are:
(a) 2,500,000 warrants issued on September 8, 2015 as part of a private placement, having an original expiry date of September 8, 2017. Each Warrant entitles the holder to purchase one common share of the Company at a price of CDN$0.13 per share. On a post-consolidation basis, these warrants are equivalent to 125,000 warrants with an exercise price of $2.60 per share;
(b) 180,000 broker warrants issued on September 23, 2015 as part of a private placement, having an original expiry date of September 23, 2017. Each Warrant entitles the holder to purchase one common share of the Company at a price of CDN$0.04 per share. On a post-consolidation basis, these warrants are equivalent to 9,000 warrants with an exercise price of $0.80 per share; and
(c) An aggregate of 2,500,000 warrants issued on October 03, 2015 as part of a private placement, having an original expiry date of October 3, 2017. Each Warrant entitles the holder to purchase one common share of the Company at a price of CDN$0.11 per share. On a post-consolidation basis, these warrants are equivalent to 125,000 warrants with an exercise price of $2.20 per share.
The expiry date of the above-listed warrants will be extended to December 29, 2017. The exercise price will be repriced to CDN$0.022 per common share, which on post-consolidation basis is equivalent to an exercise price of CDN$0.44 per common share.
None of the warrants issued under the private placements listed above have been exercised to date, and none of these warrants are held, directly or indirectly, by any insiders of the Company. The amendments to the 2017 warrants are subject to approval of the TSX. The amendment to the warrants will not become effective until at least ten business days from the date of this announcement. A further update will be made upon the TSX providing final approval for the amendment to the terms of the warrants.